Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Earnings call summary highlights declining profits across multiple segments, with significant year-over-year decreases. Despite positive outlooks in biofuels and some operational improvements, management's inability to provide clear guidance and higher costs raise concerns. The Q&A session further emphasized uncertainties and lack of precise guidance, particularly on critical factors like crush margins and RVO impacts, contributing to a negative sentiment. Although there are some positive developments, such as ethanol export potential, the overall sentiment leans negative due to the financial performance and lack of clear guidance.
Adjusted Earnings Per Share (EPS) $0.87 for Q4 2025 and $3.43 for the full year 2025. No specific year-over-year change mentioned.
Total Segment Operating Profit $821 million for Q4 2025 and $3.2 billion for the full year 2025. No specific year-over-year change mentioned.
Adjusted Return on Invested Capital (ROIC) 6.3% for the trailing 4 quarters. No specific year-over-year change mentioned.
Cash Flow from Operations Before Working Capital Changes $2.7 billion for 2025, down $600 million compared to 2024, due to lower overall total segment operating profit.
Cash Flow Benefit from Inventory Reduction $1.5 billion in 2025. No specific year-over-year change mentioned.
AS&O Segment Operating Profit $444 million for Q4 2025, down 31% year-over-year. Full year 2025 was $1.6 billion, down 34% year-over-year, due to lower North American exports, net negative timing impacts, and weaker crush margins.
Ag Services Subsegment Operating Profit $174 million for Q4 2025, down 31% year-over-year, driven by lower export activity and net negative timing impacts of $50 million.
Crushing Subsegment Operating Profit $66 million for Q4 2025, down 69% year-over-year, due to weaker crush margins, net negative timing impacts of $20 million, and reduced insurance proceeds of $20 million.
Refined Products and Other Subsegment Operating Profit $119 million for Q4 2025, down 2% year-over-year, with positive timing impacts offsetting weaker food demand and lower biodiesel and refining margins.
Equity Earnings from Wilmar $85 million for Q4 2025, up 49% year-over-year, excluding specified items. Full year 2025 was 14% lower year-over-year.
Carbohydrate Solutions Segment Operating Profit $299 million for Q4 2025, down 6% year-over-year. Full year 2025 was $1.2 billion, down 12% year-over-year, due to weakness in starches and sweeteners offset by strength in ethanol margins.
Starches and Sweeteners Operating Profit $256 million for Q4 2025, down 16% year-over-year, due to less consumption of packaged goods and high corn costs in EMEA.
Vantage Corn Processors Subsegment Operating Profit $43 million for Q4 2025, up 187% year-over-year, driven by stronger ethanol margins. Full year 2025 was up $119 million year-over-year.
Nutrition Segment Revenue $1.8 billion for Q4 2025, flat year-over-year. Human Nutrition revenue increased by 5%, while Animal Nutrition revenue decreased by 4%.
Nutrition Segment Operating Profit $78 million for Q4 2025, down 11% year-over-year, due to reduced insurance proceeds. Full year 2025 was $319 million, down 2% year-over-year.
Human Nutrition Operating Profit $56 million for Q4 2025, down 10% year-over-year, due to reduced insurance proceeds. Full year 2025 was $319 million, down 2% year-over-year.
Animal Nutrition Operating Profit $22 million for Q4 2025, down 15% year-over-year, due to localized volume softness and onetime items. Full year 2025 was $98 million, up 66% year-over-year, driven by improved margins and portfolio optimization.
Corporate and Other Business Costs Increased by 25% for Q4 2025 and 19% for full year 2025, due to higher revaluation losses, partially offset by lower interest expense and other factors.
Capital Expenditures $1.2 billion for 2025. No specific year-over-year change mentioned.
Dividends to Shareholders $987 million for 2025. No specific year-over-year change mentioned.
Enhanced Nutrition: Innovations in allergen-free pea protein, ultra-high protein drinks, protein bars, and fortified snacks.
Natural Flavors and Colors: Developed patented technology for clean citrus flavors and a breakthrough natural blue pigment for food and beverages.
Functional Ingredients: Developing next-generation ingredients combining biotics and botanicals.
China Trade Relations: Improved relations expected to support a more constructive market environment in 2026.
U.S. Biofuel Policy: Pending clarity expected to drive economic opportunities and long-term investments.
Portfolio Optimization: Executed over 20 projects, achieving $200 million in cost savings and launching a joint venture with Alltech.
Plant Efficiency: Addressed efficiency issues, reduced unplanned downtime, and achieved the lowest injury rate in company history.
Decarbonization: Connected Columbus, Nebraska plant to carbon capture infrastructure, extending capabilities.
Cash Flow Management: Realized $1.5 billion cash flow benefit from inventory reduction.
Growth Areas: Focused on enhanced nutrition, biotics, biosolutions, precision fermentation, and decarbonization for long-term value creation.
Cost Savings: Targeting $500-$750 million in aggregate cost savings over 3-5 years.
Global Trade and Biofuel Policy Landscape: The dynamic and challenging global trade and biofuel policy landscape negatively impacted the AS&O segment, with a 31% decrease in operating profit for the fourth quarter and a 34% decrease for the full year compared to 2024. Lower North American exports and a challenged global trade environment were key contributors.
Crushing Subsegment: Operating profit decreased by 69% in the fourth quarter due to weaker crush margins in North and South America, despite increased global crush volumes. Reduced insurance proceeds and net negative timing impacts further pressured results.
Starches and Sweeteners: Continued weakness in starches and sweeteners was driven by less consumption of packaged goods and persistent high corn costs in EMEA due to crop quality issues. Operating profit decreased by 16% in the fourth quarter and 21% for the full year.
Insurance Proceeds: Significant reduction in insurance proceeds related to Decatur East and West claims negatively impacted operating profits across multiple segments, including Nutrition and Carbohydrate Solutions.
Animal Nutrition: Localized volume softness and the impact of one-time items led to a 15% decrease in operating profit for the fourth quarter.
Corporate and Other Business Costs: Increased by 25% in the fourth quarter and 19% for the full year due to higher charges related to revaluation losses, including impairment, contingency, and restructuring charges.
Consumer Behavior Trends: Softness in consumer demand for packaged goods continued to impact starches and sweeteners volumes and margins, reflecting ongoing changes in consumer buying trends.
Decarbonization and Carbon Capture: While progress was made in decarbonization efforts, the financial and operational impact of these initiatives remains uncertain and could pose challenges in execution and cost management.
2026 Adjusted EPS Outlook: The company projects an adjusted EPS range of $3.60 to $4.25 for 2026, reflecting growth over 2025. This range accounts for the fluidity in timing and market response as global trade and biofuel policies evolve.
Market Environment Expectations: The company anticipates a more constructive operating environment in 2026, supported by progress in China trade relations and expected U.S. biofuel policy clarity. This is expected to benefit the AS&O business and drive long-term investment in the agriculture sector.
Carbohydrate Solutions Segment: Operating profit is expected to remain relatively flat in 2026, with lower starches and sweeteners volumes and pricing offset by higher ethanol margins.
Nutrition Segment: The segment is expected to continue its trajectory of stronger organic growth and execution, driven by growth in Flavors, recovery in Specialty Ingredients, and expansion in Health and Wellness. Animal Nutrition is expected to see margin expansion due to higher-margin products and portfolio optimization.
Ethanol Market: Robust ethanol export opportunities are expected to continue, driven by mandated markets. Domestic demand is anticipated to strengthen with U.S. biofuel policy clarity, and ethanol margin strength is expected to be supported by policy incentives.
Capital Expenditures: The company plans to invest approximately $1.3 billion to $1.5 billion in capital expenditures in 2026.
Cost Savings Initiatives: ADM remains on track to achieve targeted aggregate cost savings of $500 million to $750 million over 3 to 5 years, which began in 2025.
Dividend Payments: ADM paid its 376th consecutive quarterly dividend in the fourth quarter of 2025.
Total Dividends Paid in 2025: ADM returned $987 million in dividends to shareholders throughout 2025.
Share Repurchase Program: No specific mention of a share repurchase program was made in the transcript.
Earnings call summary highlights declining profits across multiple segments, with significant year-over-year decreases. Despite positive outlooks in biofuels and some operational improvements, management's inability to provide clear guidance and higher costs raise concerns. The Q&A session further emphasized uncertainties and lack of precise guidance, particularly on critical factors like crush margins and RVO impacts, contributing to a negative sentiment. Although there are some positive developments, such as ethanol export potential, the overall sentiment leans negative due to the financial performance and lack of clear guidance.
The earnings call summary presents a mixed outlook: strong past financial performance and optimistic guidance for certain segments, but uncertainties in biofuel policies and trade deals create risks. The Q&A reveals management's optimism about 2026 and potential benefits from joint ventures, but also highlights concerns over policy clarity and margin challenges. Although there is potential for positive developments, the lack of immediate clarity on key policies tempers expectations, resulting in a neutral sentiment.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.